Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Effect of chemotherapy and aromatase inhibitors in the adjuvant treatment of breast cancer on glucose and insulin metabolism-A systematic review

Research output: Contribution to journalReviewResearchpeer-review

DOI

  1. Impact of meningioma surgery on use of antiepileptic, antidepressant, and sedative drugs: A Swedish nationwide matched cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Long-term quality of life & functional outcomes after treatment of oropharyngeal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Depression and anxiety in Hodgkin lymphoma patients: A Danish nationwide cohort study of 945 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Impact of chronic diseases on effect of breast cancer screening

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. VPS39-deficiency observed in type 2 diabetes impairs muscle stem cell differentiation via altered autophagy and epigenetics

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mortality from cardiovascular disease in women with breast cancer - a nationwide registry study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Denosumab vs. zoledronic acid treatment in post-menopausal breast cancer: a 2-year prospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Cardiovascular disease in women with breast cancer - a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

INTRODUCTION: Breast cancer (BC) is the most common cancer among women worldwide. With increasing survival rates, focus has expanded to long-term adverse effects of adjuvant chemotherapy and/or aromatase inhibitors. Weight gain during chemotherapy has been well documented, but the underlying mechanisms remain unclear. A change in glucose and insulin metabolism is a possible consequence.

METHODS: We searched PubMed on the 4th of May 2018, and found eight articles that compared measurements of glucose and insulin before and after chemotherapy and/or aromatase inhibitors in woman with BC.

RESULTS: A general trend of increased glucose and insulin is seen and likely to be caused by weight gain and/or changes in body composition as a consequence of adjuvant treatment of BC.

DISCUSSION: Due to methodological limitations including short follow-up times and small sample sizes, further studies are required to better describe metabolic consequences of adjuvant chemotherapy and/or aromatase inhibitors. Future studies could help identify patients in high-risk of developing cardiometabolic disease after BC treatment.

Original languageEnglish
JournalCancer Medicine
Volume8
Issue number1
Pages (from-to)238-245
Number of pages8
ISSN2045-7634
DOIs
Publication statusPublished - Jan 2019

    Research areas

  • breast cancer, chemotherapy, glucose, insulin, weight gain

ID: 56225042